BiotechTube
Home/Pipeline/Oncology PPI Program(s)

Oncology PPI Program(s)

Oncology (unspecified)

Pre-clinicalActive

Key Facts

Indication
Oncology (unspecified)
Phase
Pre-clinical
Status
Active
Company
AlphaMol Science

About AlphaMol Science

AlphaMol Science is a private, pre-clinical stage biotech targeting protein-protein interactions with small molecules, a historically undruggable target class. Leveraging its location in the Basel life sciences hub, the company aims to create novel therapies for oncology, with potential expansion into other therapeutic areas. As a platform-focused company, its success hinges on validating its proprietary drug discovery technology and advancing its lead programs into clinical development to attract partnership and investment.

View full company profile

Therapeutic Areas

Oncology

Other Oncology (unspecified) Drugs

DrugCompanyPhase
Oncology Vaccine ProgramCHAIN BiotechPre-clinical
ARX305NovoCodex BiopharmaceuticalsPhase 1
ARX788NovoCodex BiopharmaceuticalsPhase 1
Cancer Immunotherapy NanotherapeuticFlashpoint TherapeuticsPhase 1
GRWD5769Greywolf TherapeuticsPhase 1/2
Platform-derived Program(s)Immuto ScientificDiscovery/Pre-clinical
MBT Oncology ProgramIonic PharmaceuticalsPre-clinical
ISB 2301Ichnos Glenmark InnovationPreclinical
GRC 65327Ichnos Glenmark InnovationPreclinical
Platform-Derived PipelinePhinomicsDiscovery/Pre-clinical
Lead Small-Molecule InhibitorEris BiotechPre-clinical
Orotecan™Edison OncologyPhase 1/2a